Count | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
Antirheumatic Agents, Gold/administration & dosage/*adverse effects | 1 |
Gold/administration & dosage/*adverse effects/*diagnostic use/immunology | 1 |
| 3 | |
| 4 | |
| 1 | |
| 5 | |
| 2 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 5 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 1 | |
| 1 | |
| 7 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 12 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 4 | |
| 3 | |
| 2 | |
| 5 | |
| 7 | |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 6 | |
| 1 | |
| 9 | |
| 10 | |
| 7 | |
| 33 | |
| 4 | |
| 3 | |
| 1 | |
| 5 | |
| 1 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 1 | |
| 2 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 16 | |
| 1 | |
| 3 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |